健康促進與衛生教育學報出版倫理聲明
Publication Ethics Statement of the Journal of Health Promotion and Health Education
健康促進與衛生教育學報致力出版健康與衛教相關領域之研究論文，刊登內容均經過公開徵稿及專業審查。
The Journal of Health Promotion and Health Education is dedicated to publishing research articles in the fields of health promotion and health education, and all published content undergoes open calls for submissions and professional peer review.
本刊要求刊登之論文均須符合出版倫理，拒絕接受涉及剽竊、一稿多投、假造(杜撰)資料、他人代為撰稿，或未揭露之利益衝突等任何不當行為的論文。
The journal requires that all submitted manuscripts comply with publication ethics and rejects any manuscripts involving misconduct such as plagiarism, duplicate submission, data fabrication or falsification, ghostwriting, or undisclosed conflicts of interest.
本刊以Elsevier建議之《出版倫理》（Publishing Ethics）（https://www.elsevier.com/about/our-business/policies/publishing-ethics），以及COPE （Committee of Publication Ethics）之出版倫理指南與規範（http://publicationethics.org/resources/guidelines）為依循。
This journal follows the Publishing Ethics guidelines recommended by Elsevier (https://www.elsevier.com/about/our-business/policies/publishing-ethics), as well as the ethical guidelines and standards established by the Committee on Publication Ethics (COPE) (http://publicationethics.org/resources/guidelines).
在評審與發表程序當中，主編、編輯委員會成員與出版方均需遵循該指南與規範，以確保避免違反出版倫理，及任何不當出版之行為。
During the review and publication process, the Editor-in-Chief, editorial board members, and the publisher shall adhere to these guidelines and standards to ensure the prevention of any violations of publication ethics or improper publishing practices.
以下將對於編輯者、審查者、作者之出版倫理要求，摘錄編彙如下：
The ethical responsibilities of editors, reviewers, and authors are summarized as follows:
編輯者的義務Duties of Editors
- 出版決定權Publication Decisions
基於「同儕評審」(peer review)的結果，可依據研究議題本身或對其他研究者或讀者的重要性，編輯者決定是否出版投稿文章。
Based on the results of peer review, editors may decide whether to publish submitted manuscripts according to the research topic itself or its importance to other researchers or readers.
編輯者需遵行相關期刊編輯指導原則與法律原則。
Editors must follow relevant journal editorial guidelines and legal requirements.
編輯者可授權評審委員會行使出版決定權。
Editors may authorize the editorial board to exercise publication decision-making authority.
- 公平競爭Fair Play
編輯者需以論文的內容進行評審，而非以作者的種族、性別、性取向、宗教信仰、國籍與政治信仰為評審標準。
Editors must evaluate manuscripts based on their content, without regard to the authors’ race, gender, sexual orientation, religious beliefs, nationality, or political views.
編輯政策應具透明度及完整，編輯者應確保評審委員會和作者對其期望有明確的了解。
Editorial policies should be transparent and complete, and editors must ensure that both reviewers and authors clearly understand expectations.
編輯者應使用期刊的標準電子提交系統進行所有期刊通訊，以確保公平性。
Editors shall use the journal’s standard electronic submission system for all communications to ensure fairness.
- 機密原則Confidentiality
編輯者與相關人員不得向相關作者、審查者、編輯顧問與出版商公開論文之任何訊息。
Editors and relevant personnel must not disclose any information about a manuscript to anyone other than the relevant author, reviewers, editorial advisors, and the publisher.
- 公開原則Disclosure Principles
- 未取得作者之同意，編輯者不得將論文中未發表資料作為個人研究之用。
Without the author’s consent, editors must not use unpublished materials from a manuscript for their own research. - 由同儕審查者所提供之相關修改建議與訊息不得挪為私人使用。
Information and revision suggestions provided by peer reviewers must not be used for personal purposes. - 當編輯者認為與投稿作者、企業與組織構成競爭、合作或其他關聯等利益衝突時，必須迴避稿件審查，並由其他符合條件之適任人員代理。
When editors believe that a conflict of interest exists due to competitive, collaborative, or other relationships with the author, enterprises, or organizations, they must recuse themselves from the review process and assign it to an appropriate individual. - 編輯者需要求所有研究貢獻者公開相關利益衝突資訊。
Editors must require all contributors to disclose relevant conflict-of-interest information.
若利益衝突於出版後被揭露，需發表更正說明或發表撤銷出版或利害關係聲明等必要措施。
If conflicts of interest are identified after publication, necessary actions such as corrections, retractions, or statements of concern must be taken.
- 未取得作者之同意，編輯者不得將論文中未發表資料作為個人研究之用。
- 利益衝突Conflicts of Interest
- 須確保相關之贊助或補助，在同儕審查的過程中沒有形成特別待遇，其審查要求與其他論文相同。
Editors must ensure that sponsorship or funding does not result in preferential treatment during peer review, and that review standards remain consistent with other manuscripts. - 贊助或補助項目須完全符合學術使用之價值，而非商業利益考量。
Sponsored or funded content must conform to academic purposes rather than commercial interests. - 若無同儕審查，須清楚揭露。
If peer review is not conducted, this must be clearly disclosed.
- 須確保相關之贊助或補助，在同儕審查的過程中沒有形成特別待遇，其審查要求與其他論文相同。
- 調查參與Investigation Involvement
當發現或接獲投稿論文違反著作倫理事件之舉報，編輯者與出版者需採取適度因應措施，包括聯繫作者或相關單位並告知其缺失。
When ethical concerns or allegations of misconduct are identified, editors and publishers must take appropriate measures, including contacting the authors or relevant institutions and informing them of the issues.
一旦確定違反學術倫理，必須立刻進行更正、撤回、釐清聲明等處理動作。
Once a violation of academic ethics is confirmed, actions such as correction, retraction, or clarification must be taken immediately.
任何違反出版倫理之行為必須深入調查，已刊登出版的論文，仍具追訴效力。
Any misconduct must be thoroughly investigated, and published articles remain subject to retrospective review.
審查者的義務Duties of Reviewers
- 審查能力Competence
被委任之審查者若認為不適任或無法及時完成審查，必須通知編輯委員會或責任編輯，並主動要求撤銷審查委員資格。
If a reviewer considers themselves unqualified or unable to complete the review in a timely manner, they must notify the editorial board or responsible editor and request to withdraw from the review process.
- 保密原則Confidentiality
審查者必須將審查的論文原稿視為機密文件，不得向編輯者以外之人透漏任何訊息。
Reviewers must treat manuscripts under review as confidential documents and must not disclose any information to anyone other than the editor.
- 客觀標準Objectivity
審查委員必須摒除個人觀點，公正且客觀地進行論文內容評審，提出具建設性的審查意見，對於論文內容之批評，且需提出確切的例證。
Reviewers must conduct evaluations impartially and objectively, without personal bias, and provide constructive comments. Criticism of the manuscript must be supported by specific examples.
- 來源告知Acknowledgment of Sources
審查者須能辨識出作者文中沒有引註的相關資料，並提出明確的相關例證，任何前人已進行之監測、調查或內容均須註明在相關引註說明中。
Reviewers must identify relevant materials not cited by the authors and provide clear supporting examples. Any prior studies, investigations, or content must be properly cited.
審查者也必須告知編輯者論文中任何可能與其他作者著作相似或部分重疊之處。
Reviewers must also inform the editor of any similarity or overlap between the manuscript and other published works.
- 公開原則與利益衝突Disclosure and Conflicts of Interest
未取得作者之同意前，審查者不得將論文中未發表資料挪為己用。
Without the author’s consent, reviewers must not use unpublished materials from the manuscript.
當審查委員認為與其他作者、企業與組織構成競爭、合作或其他關聯等利益衝突時，必須主動要求迴避審查工作。
If reviewers consider that a conflict of interest exists due to competitive, collaborative, or other relationships with authors, enterprises, or organizations, they must withdraw from the review process.
作者的義務Duties of Authors
- 論文標準Reporting Standards
作者投稿內容須依遵本學報要求，並於論文中呈現相關的研究數據，精確描述實驗或研究的進行，以客觀的論述方式呈現明確的研究結果。
Authors must prepare manuscripts in accordance with the journal’s requirements and present relevant research data, accurately describing the experimental or research process and presenting clear results in an objective manner.
論文中需明確呈現研究的重要細節，以及相關的研究與參考資料，以利他人後續之研究。
The manuscript must clearly present important research details as well as relevant studies and references to facilitate further research by others.
不得有任何違法與不道德的行為，如欺瞞、誤導、不正確或不符實之敘述等。
Any illegal or unethical behavior, such as deception, misleading statements, or inaccurate descriptions, is prohibited.
- 資料使用與保留Data Access and Retention
作者需保留原始之研究或實驗數據，於審查過程中提供給審查者進行審查，並於刊登出版後供公開使用。
Authors must retain original research or experimental data, provide them to reviewers during the review process, and make them available for public access after publication.
- 原創性與剽竊Originality and Plagiarism
作者應確保投稿之論文內容均為原創，若有使用其他作者之論述，須明確引註。
Authors must ensure that submitted work is original, and any use of others’ work must be properly cited.
不得有剽竊或抄襲等不道德與違法行為，包含私自挪用他人結論為自己成果、複製或重新闡示其他作品之精華與仿冒他人作品為自己著作。
Plagiarism or unethical and illegal conduct is prohibited, including appropriating others’ conclusions as one’s own, reproducing essential parts of other works, or presenting others’ work as one’s own.
- 複合、重複或同時出版之出版品Multiple, Redundant, or Concurrent Publication
作者不得同時於多個期刊或出版品發表本質上相同的研究論文或報告，或將同一份原稿投稿至不同刊物，此均為不符出版倫理的不當行為。
Authors must not submit the same manuscript to multiple journals simultaneously or publish substantially similar research in more than one publication, as this constitutes unethical publishing behavior.
已被發表的研究論文原則上不得再投稿至另一期刊。
Previously published research should not be submitted to another journal.
但可在特定條件下進行二次出版（secondary publication）：作者與原刊與二次出版之期刊編輯者均同意，且二次出版之資料與論述必須與原刊論文相符，而原刊論文的相關資料也必須列於二次出版論文之參考文獻內。
However, secondary publication is permitted under specific conditions: both the original and secondary journal editors must agree, the content must be consistent with the original publication, and the original work must be properly cited in the references.
- 資料來源之告知Acknowledgment of Sources
作者必須善盡告知引用他人作品的責任，並應列舉出影響研究本質的各方因素。
Authors must properly acknowledge all sources and identify factors that influence the nature of the research.
未公開的私人資訊如：對話、書信、第三方之討論等，若無資料來源方的明確書面授權函，則不應使用或發表。
Unpublished private information, such as conversations, correspondence, or third-party discussions, must not be used or published without explicit written permission from the source.
若為因審查他人著作（論文或計畫補助申請書等稿件）而獲得之資訊，如無原作者的書面授權同意，不應使用或發表。
Information obtained through the review of others’ work must not be used or published without the original author’s written consent.
- 論文作者之列名Authorship
舉凡對於論文有構思、設計、執行或闡明等重要貢獻者，均需列於共同作者之列，若有參與相關研究計畫之人員也必須詳列清楚。
All individuals who have made significant contributions to the conception, design, execution, or interpretation of the study must be listed as co-authors, and participants involved in the research project must be clearly identified.
通訊作者需確保所有具有貢獻的共同作者都列名於作者列，且對論文沒有貢獻者，不應列名。
The corresponding author must ensure that all contributing co-authors are listed and that individuals who did not contribute to the work are not listed.
通訊作者需確認每位共同作者於投稿前都完成最後投稿文件之檢視，並同意投稿。
The corresponding author must confirm that all co-authors have reviewed the final version of the manuscript and agreed to its submission.
- 危害物與人、動物之實驗對象Hazards and Human or Animal Subjects
若研究涉及會產生嚴重危害之化學品、研究過程或器具設施，作者需詳細闡述之。
If the research involves hazardous chemicals, procedures, or equipment, these must be clearly described.
若研究工作包含人類或動物等實驗對象，作者需於論文詳述過程，並確保合乎相關法律規定與制度之指導與規範。
If the research involves human or animal subjects, the procedures must be described in detail and comply with relevant laws and regulations.
對於以人類試驗對象之研究，作者需於論文內聲明進行人體試驗之同意權，且需永久保護人體試驗對象之隱私權。
For research involving human subjects, authors must state that informed consent has been obtained and ensure the permanent protection of participants’ privacy.
- 利益衝突Conflicts of Interest
作者需公開表明任何可能被視為影響研究結果或結果闡釋的利益衝突事項。
Authors must disclose any conflicts of interest that may influence the research results or their interpretation.
包含經費補助、計畫補助、僱傭關係、顧問、材料物品擁有權、報酬、專家證詞費用、專利申請／註冊或捐款授權等。
This includes funding, grants, employment, consultancy, ownership of materials, remuneration, expert testimony fees, patents, or donations.
如有未來可能利益衝突之相關資料，亦須儘早提供。
Potential future conflicts of interest must also be disclosed as early as possible.
- 研究內容之錯誤Errors in Published Work
當作者發現研究內容含有錯誤或不正確資訊，應迅速主動通知編輯者，進行撤回論文或修改內容等相關舉措。
If authors discover errors or inaccuracies in their work, they must promptly notify the editor and take actions such as correction or retraction.
若編輯者經第三方得知研究論文包含重大錯誤，作者除需採取以上動作，尚需提供編輯者正確之資訊。
If significant errors are identified by a third party, authors must also provide accurate information to the editor and cooperate in corrective actions.
在評審與發表程序當中，主編、評審委員會成員與出版者需遵守依照Committee on Publication Ethics (COPE)之指導方針：“Code of Conduct and Best Practice Guidelines for Journal Editors” 與 “Code of Conduct for Journal Publishers”，以確保沒有違反出版倫理與造成任何不當出版之行為。
During the review and publication process, the Editor-in-Chief, editorial board members, and the publisher must adhere to the guidelines of the Committee on Publication Ethics. This includes the Code of Conduct and Best Practice Guidelines for Journal Editors and the Code of Conduct for Journal Publishers, to ensure compliance with publication ethics and prevent improper publishing practices.